TROY E. WILSON - 24 Jan 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Issuer symbol
KURA
Transactions as of
24 Jan 2024
Transactions value $
-$1,291,388
Form type
4
Filing time
26 Jan 2024, 17:10:05 UTC
Previous filing
04 Jan 2024
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Options Exercise $33.3K +6.95K +1242.4% $4.80 7.5K 24 Jan 2024 Direct F1
transaction KURA Common Stock Sale -$140K -6.95K -92.55% $20.23 559 24 Jan 2024 Direct F1
transaction KURA Common Stock Options Exercise $517K +84.1K +15045.97% $6.15 84.7K 24 Jan 2024 Direct F1
transaction KURA Common Stock Sale -$1.7M -84.1K -99.34% $20.23 559 24 Jan 2024 Direct F1
holding KURA Common Stock 300K 24 Jan 2024 by Lorax Charitable Remainder Unitrust
holding KURA Common Stock 279K 24 Jan 2024 by One Fish Two Fish Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022.